May 05, 2020
Acesion Pharma Strengthens Clinical Team With Key Appointments
Mar 10, 2020
AltaThera Pharmaceuticals Announces FDA Approval for New Indications of Sotalol IV: A New and Faster Way to Initiate Sotalol Therapy for Atrial Fibrillation (AFib) Patients
Feb 28, 2020
HUYA Bioscience International® Announces the Successful Completion of Phase 1 Trial of HBI-3000
Feb 28, 2020
HUYA Bioscience International® Announces the Successful Completion of Phase 1 Trial of HBI-3000
Dec 18, 2019
ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL
Dec 10, 2019
Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess(TM) For The Treatment Of Recent Onset Atrial Fibrillation
Dec 10, 2019
Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss Brinavess(TM) For Recent Onset Atrial Fibrillation
Nov 18, 2019
Correvio Announces Presentation of New Brinavess(TM) Spectrum Data at the American Heart Association 2019 Annual Meeting
Nov 04, 2019
Correvio Announces FDA Advisory Committee Meeting to Review Brinavess(TM) for Recent Onset Atrial Fibrillation
Oct 31, 2019
ANI Announces Plans to Launch Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml) for Ventricular Arrhythmias
Sep 03, 2019
Correvio Announces Presentation Of Brinavess® Spectrum Data At The European Society Of Cardiology 2019 Congress
Aug 12, 2019
Correvio Announces Brinavess® Spectrum Data to be Presented at the European Society of Cardiology 2019 Congress
Jul 25, 2019
U.S. FDA Accepts Correvio's Resubmitted New Drug Application For Brinavess (vernakalant)
Jun 24, 2019
Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation
Mar 20, 2019
Correvio Announces Presentation Of Brinavess® Data At The American College Of Cardiology 2019 Annual Meeting
Feb 07, 2019
Correvio Announces Presentation Of Brinavess Data At Belgian Society Of Cardiology 2019 Annual Congress
Jan 09, 2019
Pii to Manufacture FDA-approved Bretylium Tosylate Injection Drug Product
Nov 05, 2018
Acesion Pharma Announces Positive Results for Novel Drug Targeting Atrial Fibrillation
Oct 29, 2018
Correvio Announces Brinavess Eligibility for Patent Extension
Oct 23, 2018
Correvio Announces Intention to Re-File Brinavess® NDA in Second Quarter 2019